Percheron Therapeutics Ltd PERCF
$0.00
Last Updated: Jul 27, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
PERCF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Percheron Therapeutics Ltd is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Percheron Therapeutics Ltd. Stock Analysis PERCF
United States Health Care Nano Cap Percheron Therapeutics Ltd. engages in the research and development of novel antisense pharmacceuticals. The company is headquartered in Melbourne, Victoria. The company went IPO on 2001-12-20. The firm is focused on the development and commercialization of novel therapies for oncology and rare diseases. The Company’s lead program is HMBD-002, a monoclonal antibody targeting the immune checkpoint regulator, VISTA. HMBD-002 has completed a phase I clinical trial in patients with advanced cancer. HMBD-002 is a recombinant humanized monoclonal IgG4 antibody to human v-domain immunoglobulin suppressor of T-cell activation (VISTA). VISTA is one of a number of novel immuno-oncology targets under investigation by pharmaceutical companies, with potential applications to a range of solid tumors and hematological malignancies.
Percheron Therapeutics Ltd (PERCF) Chart
Financial Metrics & Statements of Percheron Therapeutics Ltd (PERCF)
FAQ's for Percheron Therapeutics Ltd (PERCF)
- As of August 2026, Percheron Therapeutics Ltd PERCF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Percheron Therapeutics Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Percheron Therapeutics Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Percheron Therapeutics Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Percheron Therapeutics Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Percheron Therapeutics Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Percheron Therapeutics Ltd (PERCF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
